Targeting fibrinogen‐like protein 1 is a novel therapeutic strategy to combat obesity

Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation

(2019) Ghada Abdelmoemen et al.   Endocrine Metabolic & Immune Disorders-Drug Targets

Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle

(2018) Tae Woo Jung et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Associations of Weight Gain From Early to Middle Adulthood With Major Health Outcomes Later in Life

(2017) Yan Zheng et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Hepatic Protection Effects of Hepassocin in Hyperglycemic Crisis

(2017) Horng-Yih Ou et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Health Effects of Overweight and Obesity in 195 Countries over 25 Years

(2017)   NEW ENGLAND JOURNAL OF MEDICINE

Selenoprotein P is elevated in individuals with obesity, but is not independently associated with insulin resistance

(2017) Miaoxin Chen et al.   Obesity Research & Clinical Practice

A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes

(2016) Hung-Tsung Wu et al.   DIABETOLOGIA

Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents

(2016) Emanuele Di Angelantonio et al.   LANCET

Hepassocin is required for hepatic outgrowth during zebrafish hepatogenesis

(2015) Ming Gao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Hepatokines: unlocking the multi-organ network in metabolic diseases

(2015) Alison Iroz et al.   DIABETOLOGIA

Fibroblast growth factor-21, energy balance and obesity

(2015) Marta Giralt et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Hepassocin activates the EGFR/ERK cascade and induces proliferation of L02 cells through the Src-dependent pathway

(2014) Ming Gao et al.   CELLULAR SIGNALLING

Fetuin-A: a novel link between obesity and related complications

(2014) J F Trepanowski et al.   INTERNATIONAL JOURNAL OF OBESITY

Measurement of Visceral Fat: Should We Include Retroperitoneal Fat?

(2014) Chi-Sheng Hung et al.   PLoS One

Causal relationship between body mass index and fetuin-A level in the asian population: a bidirectional mendelian randomization study

(2013) Ammarin Thakkinstian et al.   CLINICAL ENDOCRINOLOGY

Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories

(2013) Katherine M. Flegal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The role of Hepassocin in the development of non-alcoholic fatty liver disease

(2013) Hung-Tsung Wu et al.   JOURNAL OF HEPATOLOGY

Targeted Deletion of Fibrinogen Like Protein 1 Reveals a Novel Role in Energy Substrate Utilization

(2013) Valeriy Demchev et al.   PLoS One

Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver Disease

(2013) Hae Yoon Choi et al.   Diabetes & Metabolism Journal

Measurement of Waist Circumference: Midabdominal or iliac crest?

(2012) W.-Y. Ma et al.   DIABETES CARE

Haemoglobin A1c is associated with carotid intima-media thickness in a Chinese population

(2011) Chi Sheng Hung et al.   CLINICAL ENDOCRINOLOGY

The role of C/EBPδ in the early stages of adipogenesis

(2009) Tomoaki Hishida et al.   BIOCHIMIE

Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure

(2009) C. Y. Li et al.   GUT